ArticleProbiotics and antimicrobial proteins2026
Zygosaccharomyces bailii: A Promising Probiotic Candidate for Functional Food Development.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The growing interest in functional foods is accompanied by the need to select new probiotic microorganisms. Artisanal fermented foods serve as excellent sources for identifying probiotics, particularly yeasts. In this work, two strains isolated from kombucha were identified: Zygosaccharomyces bailii (UVI60) and Z. lentus (UVI61). Strain UVI61 did not grow at 37 °C, so the evaluation of probiotic properties was carried out with strain UVI60. Z. bailii UVI60 showed excellent survival (98%) under adverse conditions involving synthetic gastric and duodenal juices. The self-aggregation capacity (97% after 4 h), cell surface hydrophobicity (85% after 48 h) and, in particular, adhesion to Caco-2 cells demonstrated its ability to adhere to the intestinal epithelium. Additionally, the strain exhibited strong antioxidant activity (86%), ability to hydrolyze bile salts and excellent coaggregation capacity (64-92%) with pathogens. Using Caenorhabditis elegans as an animal model, Z. bailii demonstrated a potential geroprotective effect by extending the mean lifespan of the worm by 12.5%. Moreover, intracellular extracts and supernatants obtained from Z. bailii showed remarkable cytotoxic activity against colon, ovarian and melanoma tumor cell lines. Z. lentus UVI61 also presented this activity, thus suggesting its potential as a postbiotic. The results confirm that the studied strains contribute to the probiotic and functional properties of kombucha and highlight the potential use of Z. bailii as a promising probiotic. Finally, Z. bailii UVI60, together with the strain Brettanomyces bruxellensis UVI56, which was previously characterized as a putative probiotic, exhibited excellent viability in different foods based on various plant food matrices, confirming its suitability for the development of new functional foods.
Indexed as
Identifiers
42348159What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.